RxNorm Semantic Concepts Index

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "".

RxCUINameTerm TypeTerm Type Description
Concepts Starting with: 100Blood group antibody WeeksDesignated preferred name (PT) 
Concepts Starting with: 101Substance with direct thrombin inhibitor mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 1026-oxoprostaglandin F1 alphaDesignated preferred name (PT) 
Concepts Starting with: 1036-mercaptopurineDesignated preferred name (PT) 
Concepts Starting with: 104Apolipoprotein BDesignated preferred name (PT) 
Concepts Starting with: 105methysergide 1 MG Oral Tablet [Sansert]Semantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name 
Concepts Starting with: 106TimololDesignated preferred name (PT) 
Concepts Starting with: 107Product containing methylprednisolone and neomycin (medicinal product)Designated preferred name (PT) 
Concepts Starting with: 108TrifluoperazineDesignated preferred name (PT) 
Concepts Starting with: 109avagard (chlorhexidine gluconate 1 % / ethanol 61 % ) Topical LotionSemantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name 
Concepts Starting with: 1108-oxyquinolDesignated preferred name (PT) 
Concepts Starting with: 111Vaginal CreamDose Form (DF) 
Concepts Starting with: 112Vinca alkaloidDesignated preferred name (PT) 
Concepts Starting with: 113WaxDesignated preferred name (PT) 
Concepts Starting with: 114Phenol sulfotransferaseDesignated preferred name (PT) 
Concepts Starting with: 115AscorbaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 116AST - aspartate transaminaseDesignated preferred name (PT) 
Concepts Starting with: 117Alupent Inhalant ProductSemantic Branded Dose Form Group (SBDG)Brand Name + Dose Form Group 
Concepts Starting with: 118Phenytek Oral ProductSemantic Branded Dose Form Group (SBDG)Brand Name + Dose Form Group 
Concepts Starting with: 119benzethonium Cl 0.15 % / benzocaine 5 % Topical SpraySemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 120AtenololDesignated preferred name (PT) 
Concepts Starting with: 121Adenosine triphosphate (ATP) citrate (pro-3S)-lyaseDesignated preferred name (PT) 
Concepts Starting with: 122Phosphatidylinositol 3-kinaseFull form of descriptor (FN) 
Concepts Starting with: 123biotin / niacinamide / panthenol / zinc pyrithione Medicated ShampooSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 124Product containing autonomic agentDesignated preferred name (PT) 
Concepts Starting with: 125ODC - Orotidine-5'-monophosphate decarboxylaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 126Home produced spiritDesignated preferred name (PT) 
Concepts Starting with: 127BIS-EMADesignated preferred name (PT) 
Concepts Starting with: 128Abortifacient agentFull form of descriptor (FN) 
Concepts Starting with: 129proparacaine hydrochloride 5 MG/ML [Minims Proxymetacaine hydrochloride]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 130Siberian elm pollen extract 20000 UNT/mL Injectable SolutionSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 131Picea abies flower bud extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 132Alpha amino isobutyric acidFull form of descriptor (FN) 
Concepts Starting with: 133Neomycin palmitateDesignated preferred name (PT) 
Concepts Starting with: 134Smilax regelii root extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 135Cascara sagrada bark extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 136AbrinFull form of descriptor (FN) 
Concepts Starting with: 137Lactobacillus acidophilus 10000000000 UNTSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 13821-deoxycortisolDesignated preferred name (PT) 
Concepts Starting with: 139BenzethoniumDesignated preferred name (PT) 
Concepts Starting with: 140CaspofunginFull form of descriptor (FN) 
Concepts Starting with: 1413,5 T>2<Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 142hypromellose 0.5 % / phenylephrine 0.12 % Ophthalmic SolutionPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 143undecylenic acid 20 % Topical SprayPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 144miconazole Vaginal Cream [Lagicam]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 1453-methylfentanylFull form of descriptor (FN) 
Concepts Starting with: 146Piperazine derivativeDesignated preferred name (PT) 
Concepts Starting with: 147B endorphinDesignated preferred name (PT) 
Concepts Starting with: 148Beta-galactosidaseDesignated preferred name (PT) 
Concepts Starting with: 149AcebutololDesignated preferred name (PT) 
Concepts Starting with: 150HexosaminidaseDesignated preferred name (PT) 
Concepts Starting with: 151Beta very low density lipoproteinSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 152BetaxololFull form of descriptor (FN) 
Concepts Starting with: 153amiloride hydrochloride 5 MG / furosemide 40 MG Oral Tablet [Frusemek]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 154NicoumaloneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 155AcetopromazineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 156Parakeet feathers specific IgEFull form of descriptor (FN) 
Concepts Starting with: 157Biological substanceDesignated preferred name (PT) 
Concepts Starting with: 1585-iodo-2'-deoxycytidineFull form of descriptor (FN) 
Concepts Starting with: 159palmitamideSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 160camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical SpraySemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 161Paracetamol-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 162AcetanilidSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 163Cholesterol in VLDL, betaDesignated preferred name (PT) 
Concepts Starting with: 164acetateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 165AcetokinaseDesignated preferred name (PT) 
Concepts Starting with: 166anti-inhibitor coagulant complex Injection [Feiba]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 167AcetazolamideTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 168Acetic acid glacialFull form of descriptor (FN) 
Concepts Starting with: 169Sweet chestnutSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 170Orthoboric acidSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 171FloricalBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 172glycerin / petrolatum / phenylephrine / shark liver oil Rectal CreamSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 173AcetohexamideTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 174ciprofloxacin Otic Suspension [Otiprio]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 1751-hydroxymethyltriazolamDesignated preferred name (PT) 
Concepts Starting with: 176Diacetyl reductaseFull form of descriptor (FN) 
Concepts Starting with: 177Acetolactate synthaseDesignated preferred name (PT) 
Concepts Starting with: 178AcetoneFull form of descriptor (FN) 
Concepts Starting with: 179LoncorBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 180Prunus cerasifera whole extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 181sodium hypochlorite 0.62 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 182Fatty-acid methyltransferaseDesignated preferred name (PT) 
Concepts Starting with: 183Arogenate dehydrogenaseDesignated preferred name (PT) 
Concepts Starting with: 184Carbohydrate deficient transferrin, asialo fractionDesignated preferred name (PT) 
Concepts Starting with: 1852-methylacetoacetyl-CoA thiolaseDesignated preferred name (PT) 
Concepts Starting with: 1863-ketoacyl-CoA thiolaseDesignated preferred name (PT) 
Concepts Starting with: 187Acetyl-coenzyme A carboxylaseFull form of descriptor (FN) 
Concepts Starting with: 188Acetyl-CoA acylaseFull form of descriptor (FN) 
Concepts Starting with: 189Human leukocyte antigen DRw12Designated preferred name (PT) 
Concepts Starting with: 1901 biotinyl-CoA synthetaseDesignated preferred name (PT) 
Concepts Starting with: 191calcium hydroxideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 192Beta-L-arabinosidaseFull form of descriptor (FN) 
Concepts Starting with: 193acetylcarnitineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 194AcetylcholineFull form of descriptor (FN) 
Concepts Starting with: 195Choline esterase IFull form of descriptor (FN) 
Concepts Starting with: 196AnticholinesteraseFull form of descriptor (FN) 
Concepts Starting with: 197NAC - N-acetyl cysteineFull form of descriptor (FN) 
Concepts Starting with: 198nadolol 40 MG / bendroflumethiazide 5 MG Oral TabletFull form of descriptor (FN) 
Concepts Starting with: 199acetyldigoxinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 200acetyleneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 201Acid esteraseFull form of descriptor (FN) 
Concepts Starting with: 202CarbimazoleDesignated preferred name (PT) 
Concepts Starting with: 203MegaceBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 204N-Acetyl-beta-glucosaminidaseFull form of descriptor (FN) 
Concepts Starting with: 205S protein complementDesignated preferred name (PT) 
Concepts Starting with: 206N-acetylprocainamideSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 207Acetylserotonin methyltransferaseFull form of descriptor (FN) 
Concepts Starting with: 208Corzide 40 MG / 5 MG Oral TabletSemantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name 
Concepts Starting with: 209PRED MILD 0.12 % Ophthalmic SuspensionSemantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name 
Concepts Starting with: 210AcetyltransferaseFull form of descriptor (FN) 
Concepts Starting with: 211TopicyclineBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 212Hb 80(EF4), Asp-asnFull form of descriptor (FN) 
Concepts Starting with: 213chlordiazepoxide hydrochloride 10 MG Oral Capsule [Libritabs]Semantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name 
Concepts Starting with: 214Acid lipaseDesignated preferred name (PT) 
Concepts Starting with: 215PurgativeFull form of descriptor (FN) 
Concepts Starting with: 216Child SilapapBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 21712 HR dextromethorphan HBr 50 MG / guaifenesin 400 MG / K+ guaiacolsulfonate 200 MG Extended Release Oral CapsuleTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 218ceFAZolinDesignated preferred name (PT) 
Concepts Starting with: 219Acid phosphomonoesteraseFull form of descriptor (FN) 
Concepts Starting with: 220Special CBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 221ZartanBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 222L-3-aminoisobutyrateFull form of descriptor (FN) 
Concepts Starting with: 223Cefalexin-containing productDesignated preferred name (PT) 
Concepts Starting with: 224Simple syrupFull form of descriptor (FN) 
Concepts Starting with: 225Liquifilm TearsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 226Marcain HeavyBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 227CeruloplasminFull form of descriptor (FN) 
Concepts Starting with: 228Venombin ADesignated preferred name (PT) 
Concepts Starting with: 229dichlorobenzyl alcoholIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 230Genetically modified virusFull form of descriptor (FN) 
Concepts Starting with: 231Dihydrodipicolinate synthaseFull form of descriptor (FN) 
Concepts Starting with: 232MCFFull form of descriptor (FN) 
Concepts Starting with: 233Prostaglandin PGF2 alpha tromethamineFull form of descriptor (FN) 
Concepts Starting with: 234dipipanoneFull form of descriptor (FN) 
Concepts Starting with: 235Deoxyribonucleic acid beta-glucosyltransferaseDesignated preferred name (PT) 
Concepts Starting with: 236acidulated phosphate fluorideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 237LevomethadylIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 238estradiol 0.05 MG/Day Weekly Transdermal SystemSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 239AclarubicinDesignated preferred name (PT) 
Concepts Starting with: 240Chlorphenamine-containing productDesignated preferred name (PT) 
Concepts Starting with: 241AconitaseFull form of descriptor (FN) 
Concepts Starting with: 242aconiteIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 243NH4Cl 200 MG / Guaifenesin 100 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 244Cholesterol desmolaseDesignated preferred name (PT) 
Concepts Starting with: 245Choline acetylaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 246Mephobarbital 90 MG / DPH 60 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 247zinc pyrithione 2 MG/ML [Head & Shoulders]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 248chloramphenicol 4 MG/ML Ophthalmic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 249euflavineFull form of descriptor (FN) 
Concepts Starting with: 250Fibrinogen Seattle IIDesignated preferred name (PT) 
Concepts Starting with: 251ketotifen 1 MG / theophylline 200 MG Extended Release Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 252vitamin K3 10 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 253Chymotrypsin A and BIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 254CilastatinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 255AcrosinDesignated preferred name (PT) 
Concepts Starting with: 256ephedrine hydrochloride 4.7 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 257Gentamicin acetyltransferase 1Full form of descriptor (FN) 
Concepts Starting with: 258ClenbuterolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 259ClobetasolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 260Glycerophosphocholine phosphodiesteraseFull form of descriptor (FN) 
Concepts Starting with: 261camphor 5 % / menthol 6 % Topical CreamSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 262Actin-binding proteinFull form of descriptor (FN) 
Concepts Starting with: 263TositumomabIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 264TrichomycinDesignated preferred name (PT) 
Concepts Starting with: 265Cobra venomDesignated preferred name (PT) 
Concepts Starting with: 266CoccidioidinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 267Methyl morphineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 268Acyl-CoA reductaseDesignated preferred name (PT) 
Concepts Starting with: 269HDL2 - High density lipoprotein subfraction 2Designated preferred name (PT) 
Concepts Starting with: 270SpectinomycinFull form of descriptor (FN) 
Concepts Starting with: 271ActinDesignated preferred name (PT) 
Concepts Starting with: 272Charcoal activatedSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 273hylanIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 274ActomyosinSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 275Complement component C1Designated preferred name (PT) 
Concepts Starting with: 276Active C3bFull form of descriptor (FN) 
Concepts Starting with: 277C6 - complement component 6Full form of descriptor (FN) 
Concepts Starting with: 278C5b-9 - complement 5b-9 complexSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 279isoconazoleDesignated preferred name (PT) 
Concepts Starting with: 280Acute phase reactantDesignated preferred name (PT) 
Concepts Starting with: 281Aciclovir-containing productSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 282Ketorolac trometamolDesignated preferred name (PT) 
Concepts Starting with: 283Acyl coenzyme ADesignated preferred name (PT) 
Concepts Starting with: 284travoprost 0.004 % Ophthalmic SolutionSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 285CMPsialate pyrophosphorylaseDesignated preferred name (PT) 
Concepts Starting with: 286LTA-4 hydrolaseFull form of descriptor (FN) 
Concepts Starting with: 287lidamidineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 28817,21-hydroxyprogesteroneDesignated preferred name (PT) 
Concepts Starting with: 289Tetracosactide-containing productSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 2906-aminopurineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 291CKBB - Creatine kinase BB isoenzymeDesignated preferred name (PT) 
Concepts Starting with: 292Maleylacetate reductaseFull form of descriptor (FN) 
Concepts Starting with: 293TransphosphoribosidaseDesignated preferred name (PT) 
Concepts Starting with: 294CryoglobulinDesignated preferred name (PT) 
Concepts Starting with: 295meningococcal group A polysaccharideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 296AdenosineDesignated preferred name (PT) 
Concepts Starting with: 297CyclandelateDesignated preferred name (PT) 
Concepts Starting with: 298N-Methylglutamate synthaseFull form of descriptor (FN) 
Concepts Starting with: 299methylnicotinateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 300CyclopenthiazideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 301MMDASynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 302mofebutazoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 303ADA - Adenosine deaminaseDesignated preferred name (PT) 
Concepts Starting with: 304ADPDesignated preferred name (PT) 
Concepts Starting with: 305ProtocollagenDesignated preferred name (PT) 
Concepts Starting with: 306Cytochrome p-450 enzymeDesignated preferred name (PT) 
Concepts Starting with: 307etoricoxibFull form of descriptor (FN) 
Concepts Starting with: 308Adenosine kinaseDesignated preferred name (PT) 
Concepts Starting with: 309AMPSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 310Actinomycin DDesignated preferred name (PT) 
Concepts Starting with: 311DDDSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 312ATPaseFull form of descriptor (FN) 
Concepts Starting with: 313sodium chloride 0.9 % Nasal SolutionFull form of descriptor (FN) 
Concepts Starting with: 314Ca^2+^-transporting adenosine triphosphataseFull form of descriptor (FN) 
Concepts Starting with: 315benzalkonium 0.2 MG/ML / chloroxylenol 1 MG/ML / hydrocortisone 10 MG/ML Otic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 316glycopyrrolate 1 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 317Na^+^/K^+^-transporting adenosine triphosphataseDesignated preferred name (PT) 
Concepts Starting with: 318ATP - Adenosine triphosphateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 319nitroxolineFull form of descriptor (FN) 
Concepts Starting with: 320Norleucine aminotransferaseFull form of descriptor (FN) 
Concepts Starting with: 3213',5'-cyclic AMP synthetaseFull form of descriptor (FN) 
Concepts Starting with: 322MyokinaseFull form of descriptor (FN) 
Concepts Starting with: 323AdenylosuccinaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 324IMP-aspartate ligaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 325DesmopressinFull form of descriptor (FN) 
Concepts Starting with: 326oxaprozinDesignated preferred name (PT) 
Concepts Starting with: 327DexolBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 328Palladium chlorideDesignated preferred name (PT) 
Concepts Starting with: 329DextromoramideFull form of descriptor (FN) 
Concepts Starting with: 330methacycline 300 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 331DialysateDesignated preferred name (PT) 
Concepts Starting with: 332Adipex-PBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 333adiphenineDesignated preferred name (PT) 
Concepts Starting with: 334mebendazole 40 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 335Clodronic acidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 336ImmunostimulantFull form of descriptor (FN) 
Concepts Starting with: 337trimipramine 75 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 338rRNA N-glycosidaseDesignated preferred name (PT) 
Concepts Starting with: 339StilbestrolSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 340Digitalis glycosideDesignated preferred name (PT) 
Concepts Starting with: 341anidulafunginFull form of descriptor (FN) 
Concepts Starting with: 342Polyphosphate kinaseDesignated preferred name (PT) 
Concepts Starting with: 343dihydroxyacetoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 344prenylamine lactateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 345GQ1b ganglioside antibodyDesignated preferred name (PT) 
Concepts Starting with: 346leuprolide 22.5 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 347nitrogen 99.5 % Gas for InhalationPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 348oxygen 99.1 % Gas for InhalationPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 349lamoTRIgine 2 MG Chewable Dispersible TabletDesignated preferred name (PT) 
Concepts Starting with: 350DiphenoxylateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 351Diphtheria immunoglobulinFull form of descriptor (FN) 
Concepts Starting with: 352DiprenorphineDesignated preferred name (PT) 
Concepts Starting with: 353Tannic-12 SBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 354Adrenal cortical hormone-containing productDesignated preferred name (PT) 
Concepts Starting with: 355RibokinaseFull form of descriptor (FN) 
Concepts Starting with: 356Phosphoribulose epimeraseDesignated preferred name (PT) 
Concepts Starting with: 357Thiazide diureticFull form of descriptor (FN) 
Concepts Starting with: 358roxatidine acetatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. 
Concepts Starting with: 359Accuzyme 830,000 UNT/GM / 10 % Topical OintmentPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 360S-Alkylcysteine lyaseFull form of descriptor (FN) 
Concepts Starting with: 361salicinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 362Adrenaline hydrochlorideSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 363tinzaparin Injectable Solution [Innohep]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 364DoxycyclineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 365SialooligosaccharideDesignated preferred name (PT) 
Concepts Starting with: 366Substance with alpha adrenergic receptor agonist mechanism of actionFull form of descriptor (FN) 
Concepts Starting with: 367Substance with alpha adrenergic receptor antagonist mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 368Beta-1 adrenergic receptorFull form of descriptor (FN) 
Concepts Starting with: 369Beta-2 adrenergic receptorDesignated preferred name (PT) 
Concepts Starting with: 370Substance with beta adrenergic receptor agonist mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 371Beta blockerDesignated preferred name (PT) 
Concepts Starting with: 372edrophonium Injectable SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 373Sucrose glucosyltransferaseDesignated preferred name (PT) 
Concepts Starting with: 374Substance with adrenergic receptor agonist mechanism of actionFull form of descriptor (FN) 
Concepts Starting with: 375AdrenochromeDesignated preferred name (PT) 
Concepts Starting with: 376CorticotrophinDesignated preferred name (PT) 
Concepts Starting with: 377calcium iodized / peptone,dried / thyroid (USP) Oral TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 378Elapid venomDesignated preferred name (PT) 
Concepts Starting with: 379ascorbic acid / ferrous gluconate / vitamin B12 Oral TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 380Sporothrix species antibodyFull form of descriptor (FN) 
Concepts Starting with: 381torsemide Oral Tablet [Torem]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 382EmetineFull form of descriptor (FN) 
Concepts Starting with: 383TioxidazoleDesignated preferred name (PT) 
Concepts Starting with: 384AtomoxetineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 385fluocinonide Topical SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 386fosfestrol Oral Tablet [Honvan]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 387hypromellose 0.32 % Ophthalmic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 388Polymyxin B sulfateDesignated preferred name (PT) 
Concepts Starting with: 389Mite specific IgGDesignated preferred name (PT) 
Concepts Starting with: 390IV fluidSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 391Ubiquitin--protein ligaseDesignated preferred name (PT) 
Concepts Starting with: 392EnfluraneDesignated preferred name (PT) 
Concepts Starting with: 393Ribonucleic acid uridylyltransferaseFull form of descriptor (FN) 
Concepts Starting with: 394AFT - AflatoxinDesignated preferred name (PT) 
Concepts Starting with: 395VLDL - Very low density lipoprotein triglycerideDesignated preferred name (PT) 
Concepts Starting with: 396Substance with enzyme mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 397agarIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 398XamoterolDesignated preferred name (PT) 
Concepts Starting with: 399EpimeraseDesignated preferred name (PT) 
Concepts Starting with: 400AgglutininFull form of descriptor (FN) 
Concepts Starting with: 401GP120 V-FMS proteinDesignated preferred name (PT) 
Concepts Starting with: 402ZOLMitriptan 5 MG/ACTUAT Nasal SprayDesignated preferred name (PT) 
Concepts Starting with: 403sulfamethoxazole / trimethoprim Injectable Solution [Bactrim]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 404Eritrityl tetranitrateFull form of descriptor (FN) 
Concepts Starting with: 405DispermoxBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 406ErythroseDesignated preferred name (PT) 
Concepts Starting with: 407Azinphos-ethylDesignated preferred name (PT) 
Concepts Starting with: 408Cricetinae proteinSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 409Estramustine sodium phosphateDesignated preferred name (PT) 
Concepts Starting with: 410EstrogenSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 411medical airFull form of descriptor (FN) 
Concepts Starting with: 412diethylpropion 60 MG Extended Release Oral CapsuleSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 413Inosine monophosphate cyclohydrolaseDesignated preferred name (PT) 
Concepts Starting with: 414Ethyl biscoumacetateFull form of descriptor (FN) 
Concepts Starting with: 415Monobasic Pot phosphate 6 MMOL/ML Injectable SolutionSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 416ISOtretinoin 0.00025 MG/MG Topical GelTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 417Etynodiol diacetateDesignated preferred name (PT) 
Concepts Starting with: 418EtorphineDesignated preferred name (PT) 
Concepts Starting with: 419lidocaine 50 MG/MG / triamcinolone 0.25 MG/MG Topical OintmentSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 420cefatrizine 100 MG/ML Oral SuspensionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 421cetrimide 15 MG/ML Topical SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 422glycerin 634 MG/ML Oral SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 423ajmalineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 424Human platelet antigenDesignated preferred name (PT) 
Concepts Starting with: 425Activated Christmas FactorSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 426Alpha-aminopropionic acidDesignated preferred name (PT) 
Concepts Starting with: 427ALT - alanine aminotransferaseFull form of descriptor (FN) 
Concepts Starting with: 428Alanine racemaseFull form of descriptor (FN) 
Concepts Starting with: 429Alanyl-tRNA synthetaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 430AlbendazoleFull form of descriptor (FN) 
Concepts Starting with: 431buclizine 12.5 MG / Hydroxyzine 10 MG / vit-B3 25 MG Oral TabletTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 432progabide 300 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 433AlbuminDesignated preferred name (PT) 
Concepts Starting with: 434sulfathiazole 500 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 435Salbutamol-containing productFull form of descriptor (FN) 
Concepts Starting with: 436lecithin 600 MG Oral CapsulePrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 437alibendol 100 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 438bromelains 45 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 439ADH - Alcohol dehydrogenaseDesignated preferred name (PT) 
Concepts Starting with: 440HLA AbSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 441ketanserin Topical GelSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 442Fish venomFull form of descriptor (FN) 
Concepts Starting with: 443hydroxypropylcellulose 5 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 444FlavoxateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 445FluconazoleIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 446FlunitrazepamFull form of descriptor (FN) 
Concepts Starting with: 447oxilofrine 32 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 448Ethyl alcoholDesignated preferred name (PT) 
Concepts Starting with: 449FluorometholoneDesignated preferred name (PT) 
Concepts Starting with: 450Fludroxycortide-containing productSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 451propafenone 10 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 452theophylline 40 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 453FormaldehydeFull form of descriptor (FN) 
Concepts Starting with: 454FIGLUDesignated preferred name (PT) 
Concepts Starting with: 455Product containing alcohol (product)Full form of descriptor (FN) 
Concepts Starting with: 456FFP - Fresh frozen plasmaDesignated preferred name (PT) 
Concepts Starting with: 457Fruit sugarSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 458Human follicle stimulating hormoneFull form of descriptor (FN) 
Concepts Starting with: 459FumaraseFull form of descriptor (FN) 
Concepts Starting with: 460AlcuroniumDesignated preferred name (PT) 
Concepts Starting with: 461Aldehyde dehydrogenase (nicotinamide adenine dinucleotide ^+^)Full form of descriptor (FN) 
Concepts Starting with: 462GAG-ONC proteinFull form of descriptor (FN) 
Concepts Starting with: 463Galactose-1-phosphate uridyl transferaseFull form of descriptor (FN) 
Concepts Starting with: 464Annexin IVDesignated preferred name (PT) 
Concepts Starting with: 465Aldehyde-lyaseDesignated preferred name (PT) 
Concepts Starting with: 466AldehydeFull form of descriptor (FN) 
Concepts Starting with: 467Recombinant human soluble insulinFull form of descriptor (FN) 
Concepts Starting with: 468BasaljelBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 469benzoxonium chloridePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. 
Concepts Starting with: 470Substance with protein kinase inhibitor mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 471Aldose reductaseDesignated preferred name (PT) 
Concepts Starting with: 472Blasticidin-S deaminaseFull form of descriptor (FN) 
Concepts Starting with: 473brain-derived neurotrophic factorIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 474General anesthetic agentsDesignated preferred name (PT) 
Concepts Starting with: 475Substance with aldosterone receptor antagonist mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 476E. coli exonuclease ISynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 477diphenhydramine citrate 19 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 478Oxytetracycline hydrochlorideFull form of descriptor (FN) 
Concepts Starting with: 479AlfentaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 480AlfentanilTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 481ThornDesignated preferred name (PT) 
Concepts Starting with: 482ClavulanateSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 483acetaminophen 10 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 484Walnut tree dustDesignated preferred name (PT) 
Concepts Starting with: 485D-glucoseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 486chlorothen 0.6 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 487GlucosidaseDesignated preferred name (PT) 
Concepts Starting with: 488Glutamate decarboxylaseDesignated preferred name (PT) 
Concepts Starting with: 489L-glutathioneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 490Glutathione S-alkyltransferaseFull form of descriptor (FN) 
Concepts Starting with: 491GlycerolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 492HydrostatBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 493PegintronBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 494Alkaline phosphomonoesteraseDesignated preferred name (PT) 
Concepts Starting with: 495ThiocylBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 496AlkaloidFull form of descriptor (FN) 
Concepts Starting with: 497PrialtBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 498AurothioglucoseDesignated preferred name (PT) 
Concepts Starting with: 499Cottonseed meal toxinSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 500FerrlecitBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 501GramicidinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 502FrigidermBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 503GuaiacolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 504Alkylating agentFull form of descriptor (FN) 
Concepts Starting with: 505DinitroglycerolSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 506GoserelinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 507halofantrineFull form of descriptor (FN) 
Concepts Starting with: 5085-ureidohydantoinFull form of descriptor (FN) 
Concepts Starting with: 509HaloperidolDesignated preferred name (PT) 
Concepts Starting with: 510HarmidineDesignated preferred name (PT) 
Concepts Starting with: 511Human chorionic gonadotrophin, alpha subunitSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 512Hyocholic acidDesignated preferred name (PT) 
Concepts Starting with: 513AllethrinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 514He - HeliumIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 515HaematinDesignated preferred name (PT) 
Concepts Starting with: 516allobarbitalFull form of descriptor (FN) 
Concepts Starting with: 517Threo 2-amino 3-methylpentanoic acidFull form of descriptor (FN) 
Concepts Starting with: 518Allophanate hydrolaseDesignated preferred name (PT) 
Concepts Starting with: 519AllopurinolDesignated preferred name (PT) 
Concepts Starting with: 520Allosteric siteDesignated preferred name (PT) 
Concepts Starting with: 521HemopexinFull form of descriptor (FN) 
Concepts Starting with: 522Hemostatic agentDesignated preferred name (PT) 
Concepts Starting with: 523Hepatitis antibodyFull form of descriptor (FN) 
Concepts Starting with: 524manganese gluconateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 525AllylestrenolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 526Methionine aminopeptidaseDesignated preferred name (PT) 
Concepts Starting with: 527Metubine IodideBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 528AlmitrineDesignated preferred name (PT) 
Concepts Starting with: 529almitrine dimesylatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. 
Concepts Starting with: 530HexestrolDesignated preferred name (PT) 
Concepts Starting with: 531Beta-N-acetylhexosaminidase BFull form of descriptor (FN) 
Concepts Starting with: 532HexylresorcinolFull form of descriptor (FN) 
Concepts Starting with: 533Diamine oxidaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 534A-1ACT - alpha-1-antichymotrypsinFull form of descriptor (FN) 
Concepts Starting with: 535AAT - alpha-1-antitrypsinSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 536Histone kinaseFull form of descriptor (FN) 
Concepts Starting with: 537nomegestrol acetatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. 
Concepts Starting with: 538Human leukocyte antigen ABritish synonym (SYGB)British synonym of another TTY, given for clarity. 
Concepts Starting with: 539HLA - Human leukocyte antigen B8Designated preferred name (PT) 
Concepts Starting with: 540A-2M - alpha-2 macroglobulinFull form of descriptor (FN) 
Concepts Starting with: 541Interferon alfaFull form of descriptor (FN) 
Concepts Starting with: 542guaifenesin 600 MG / phenylephrine hydrochloride 18 MG Extended Release Oral TabletTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 543Miltuss EXBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 544Alpha-fetoglobulinFull form of descriptor (FN) 
Concepts Starting with: 545Alpha globulinFull form of descriptor (FN) 
Concepts Starting with: 546brompheniramine / hydrocodone / pseudoephedrine Oral Solution [Bromplex HD]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 547HydralazineFull form of descriptor (FN) 
Concepts Starting with: 548Chlorinated hydrocarbonDesignated preferred name (PT) 
Concepts Starting with: 549PolicresulenFull form of descriptor (FN) 
Concepts Starting with: 550dibasic potassium phosphateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 551Prohormone converting enzymeDesignated preferred name (PT) 
Concepts Starting with: 552HydroxychloroquineFull form of descriptor (FN) 
Concepts Starting with: 553hydroxyestronesIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 554Hydroxymethylglutaryl-coenzyme A synthaseFull form of descriptor (FN) 
Concepts Starting with: 555Hydroxycarbamide-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 556Rhizopus aspartic proteinaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 559Hypnotic agentFull form of descriptor (FN) 
Concepts Starting with: 560alpha-amylaseDesignated preferred name (PT) 
Concepts Starting with: 561sennoside BDesignated preferred name (PT) 
Concepts Starting with: 562cephalexin Chewable TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 563pirbuterol 1.5 MG/ML [Exirel]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 564p-Isobutylhydratropic acidDesignated preferred name (PT) 
Concepts Starting with: 565IdarubicinDesignated preferred name (PT) 
Concepts Starting with: 566Immunoglobulin A1Designated preferred name (PT) 
Concepts Starting with: 567IgG2 - Immunoglobulin G2Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 568ofloxacin 300 MG [Floxin]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 569EflornithineDesignated preferred name (PT) 
Concepts Starting with: 570acetaminophen 325 MG [Uni-Ace]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 571Immunoglobulin fragmentDesignated preferred name (PT) 
Concepts Starting with: 572Igs - ImmunoglobulinsFull form of descriptor (FN) 
Concepts Starting with: 573Lambda light chainSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 574estradiol 0.0006 MG/MG [Oestrogel]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 575MaltaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 576ezetimibe 10 MG [Zetia]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 577estradiol 0.45 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 578bromfenac 0.9 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 579Minor lactalbuminSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 580petrolatum 0.568 MG/MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 581lactase 15 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 582isopropyl alcohol 0.95 ML/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 583Alpha-MSHDesignated preferred name (PT) 
Concepts Starting with: 584Infant formulaDesignated preferred name (PT) 
Concepts Starting with: 585Insulin solubleDesignated preferred name (PT) 
Concepts Starting with: 586Active C14b2aDesignated preferred name (PT) 
Concepts Starting with: 587Insulin proteaseFull form of descriptor (FN) 
Concepts Starting with: 588Interferon alfa-2bFull form of descriptor (FN) 
Concepts Starting with: 589B-cell growth factorIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 590EtazocineFull form of descriptor (FN) 
Concepts Starting with: 591Actiniaria venomFull form of descriptor (FN) 
Concepts Starting with: 592IF - Intrinsic factorIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 593chromium picolinateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 594AlphaprodineFull form of descriptor (FN) 
Concepts Starting with: 595algestoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 596AlprazolamIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 597AlprenololDesignated preferred name (PT) 
Concepts Starting with: 598Prostaglandin PGE1Ingredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 599AlseroxylonDesignated preferred name (PT) 
Concepts Starting with: 600Human leucocyte antigen Bw75Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 601IsocarboxazidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 602dorzolamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 603sodium phosphate 1500 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 604Hb 22(B4), Glu-glnFull form of descriptor (FN) 
Concepts Starting with: 605Donatussin MAXBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 606Moisture Eyes PMBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 607pregabalin 100 MG [Lyrica]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 608meperidine Oral SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 609tocamphylIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 610Lymphocyte antigen CD66BDesignated preferred name (PT) 
Concepts Starting with: 611Aluminum aspirinBritish preferred term (PTGB) 
Concepts Starting with: 612AlgeldrateDesignated preferred name (PT) 
Concepts Starting with: 613Aluminium hydroxide gelFull form of descriptor (FN) 
Concepts Starting with: 614ExjadeBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 615Aluminium oxideFull form of descriptor (FN) 
Concepts Starting with: 616OrenciaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 617Type IV collagenaseDesignated preferred name (PT) 
Concepts Starting with: 618KynureninFull form of descriptor (FN) 
Concepts Starting with: 619AmanitotoxinDesignated preferred name (PT) 
Concepts Starting with: 620AmantadineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 621Amantadine sulfateFull form of descriptor (FN) 
Concepts Starting with: 622Product containing benzalkonium and cetrimide (medicinal product)Full form of descriptor (FN) 
Concepts Starting with: 623AmbenoniumDesignated preferred name (PT) 
Concepts Starting with: 624Ambestigmine chlorideDesignated preferred name (PT) 
Concepts Starting with: 625AmbroxolFull form of descriptor (FN) 
Concepts Starting with: 626Mecillinam-containing productFull form of descriptor (FN) 
Concepts Starting with: 627Pivmecillinam-containing productSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 628Absorbable gelatin spongeDesignated preferred name (PT) 
Concepts Starting with: 629By AcheBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 630hydrofluoric acid 5 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 631citric acid 32.4 MG/ML / magnesium oxide 3.8 MG/ML / sodium carbonate 4.3 MG/ML [Urologic G]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 632Mitomycin-CSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 633Hemofiltration solutionFull form of descriptor (FN) 
Concepts Starting with: 635TransamidinaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 636Keratol HCBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 637LevallorphanFull form of descriptor (FN) 
Concepts Starting with: 638Phosphoribosyldiphosphate 5-amidotransferaseDesignated preferred name (PT) 
Concepts Starting with: 639Amidotrizoic acidDesignated preferred name (PT) 
Concepts Starting with: 640linoleic acidPrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. 
Concepts Starting with: 641AmikacinFull form of descriptor (FN) 
Concepts Starting with: 642LipopolysaccharideFull form of descriptor (FN) 
Concepts Starting with: 643Amikacin sulfateDesignated preferred name (PT) 
Concepts Starting with: 644AmilorideDesignated preferred name (PT) 
Concepts Starting with: 645Aminoacridine-containing productSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 646fluconazole 200 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 647LorazepamFull form of descriptor (FN) 
Concepts Starting with: 648ferrous fumarate 322 MG / folic acid 350 MCG Oral TabletDesignated preferred name (PT) 
Concepts Starting with: 651LymecyclineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 652LymphokineDesignated preferred name (PT) 
Concepts Starting with: 653LypressinDesignated preferred name (PT) 
Concepts Starting with: 654Ethopropazine hydrochlorideSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 655acetaminophen / caffeine / salicylamide Oral CapsuleSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 656Amino-acid racemaseFull form of descriptor (FN) 
Concepts Starting with: 657MafenideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 658Magnesium hydrateSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 659Branched-chain amino acidFull form of descriptor (FN) 
Concepts Starting with: 660Malic dehydrogenaseDesignated preferred name (PT) 
Concepts Starting with: 661CervarixBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 662Dicarboxylic amino acidDesignated preferred name (PT) 
Concepts Starting with: 663Essential amino acidDesignated preferred name (PT) 
Concepts Starting with: 664KemstroBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 665Sulfur-bearing amino acidFull form of descriptor (FN) 
Concepts Starting with: 666MaxataseFull form of descriptor (FN) 
Concepts Starting with: 667diethylpropion Extended Release Oral Tablet [Tepanil]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 668MedazepamFull form of descriptor (FN) 
Concepts Starting with: 669MedrogestoneFull form of descriptor (FN) 
Concepts Starting with: 670linezolid 400 MG Oral Tablet [Zyvox]Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 671MelarsoprolFull form of descriptor (FN) 
Concepts Starting with: 672chlorpheniramine / hydrocodone / phenylephrine Oral Solution [NUDAL HD]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 673Beta-alanine-oxoglutarate aminotransferaseFull form of descriptor (FN) 
Concepts Starting with: 674PhosphoadenylylsulfataseBritish synonym (SYGB)British synonym of another TTY, given for clarity. 
Concepts Starting with: 675MentholIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 676MeprobamateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 677AminoglutethimideFull form of descriptor (FN) 
Concepts Starting with: 678AminoglycosideDesignated preferred name (PT) 
Concepts Starting with: 679Antigen Ki67Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 6804-hydroxybenzoate-CoA synthetaseDesignated preferred name (PT) 
Concepts Starting with: 681piroxicam-beta-cyclodextrinFull form of descriptor (FN) 
Concepts Starting with: 682AIB - Aminoisobutyric acidDesignated preferred name (PT) 
Concepts Starting with: 683ALA - delta-aminolevulinic acidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 684Aminolevulinate dehydrataseDesignated preferred name (PT) 
Concepts Starting with: 685Aminolevulinate synthaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 686MethyclothiazideFull form of descriptor (FN) 
Concepts Starting with: 687Peptidase aDesignated preferred name (PT) 
Concepts Starting with: 688salicylic acid 0.03 MG/MG [Keralyt]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 689AminophyllineDesignated preferred name (PT) 
Concepts Starting with: 690AQP-2Designated preferred name (PT) 
Concepts Starting with: 691Beta-aminopropionitrileSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 692MetrizamideDesignated preferred name (PT) 
Concepts Starting with: 693ethynodiol / mestranolMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. 
Concepts Starting with: 694benzocaine 63 MG/ML [Anbesol]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 695AminophenazoneFull form of descriptor (FN) 
Concepts Starting with: 696MidazolamIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 697LeucenineDesignated preferred name (PT) 
Concepts Starting with: 698MinocyclineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 699MisonidazoleDesignated preferred name (PT) 
Concepts Starting with: 700cider vinegar 300 MG Oral TabletPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 701Lactobacillus bifidus 25 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 702menthol / methyl salicylate / methylnicotinate Topical CreamSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 703AmiodaroneFull form of descriptor (FN) 
Concepts Starting with: 704AmitriptylineFull form of descriptor (FN) 
Concepts Starting with: 705cefixime 40 MG/ML [Suprax]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 706Glucose dehydrogenaseFull form of descriptor (FN) 
Concepts Starting with: 707Non-human hair - materialDesignated preferred name (PT) 
Concepts Starting with: 708Ammonia-lyaseFull form of descriptor (FN) 
Concepts Starting with: 709ammoniumIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 710Product containing codeine and guaiacol (medicinal product)Designated preferred name (PT) 
Concepts Starting with: 711VyvanseBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 712Ammonium chlorideDesignated preferred name (PT) 
Concepts Starting with: 713Erythropoetin deltaFull form of descriptor (FN) 
Concepts Starting with: 714Product containing cefuroxime and metronidazole (medicinal product)Designated preferred name (PT) 
Concepts Starting with: 715PrimperanBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 716AbsintheDesignated preferred name (PT) 
Concepts Starting with: 717Dioctyl sodium sulfosuccinateFull form of descriptor (FN) 
Concepts Starting with: 718Myosin adenosine triphosphataseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 719AmylobarbitoneSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 720AmodiaquineDesignated preferred name (PT) 
Concepts Starting with: 721Arylamine sulfotransferaseDesignated preferred name (PT) 
Concepts Starting with: 722AmoxapineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 723AmoxicillinDesignated preferred name (PT) 
Concepts Starting with: 724AMP aminaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 725Amfetamine-containing productDesignated preferred name (PT) 
Concepts Starting with: 726guaiacolsulfonate / HYDROcodone Oral Solution [Atuss EX]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 727Natriuretic hormoneSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 728Amphibian venomDesignated preferred name (PT) 
Concepts Starting with: 729Superparamagnetic iron oxideFull form of descriptor (FN) 
Concepts Starting with: 730Neomycin sulfateDesignated preferred name (PT) 
Concepts Starting with: 731aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable TabletPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 732Amphotericin BFull form of descriptor (FN) 
Concepts Starting with: 733AminobenzylpenicillinFull form of descriptor (FN) 
Concepts Starting with: 734O-desmethylvenlafaxineSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 735Lysine racemaseDesignated preferred name (PT) 
Concepts Starting with: 736Depolarizing agentFull form of descriptor (FN) 
Concepts Starting with: 737paricalcitolDesignated preferred name (PT) 
Concepts Starting with: 738Amrinone-containing productDesignated preferred name (PT) 
Concepts Starting with: 739AmsacrineFull form of descriptor (FN) 
Concepts Starting with: 740NiclosamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 741TreandaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 742Amyl nitriteDesignated preferred name (PT) 
Concepts Starting with: 743AmylaseIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 744NitrazepamDesignated preferred name (PT) 
Concepts Starting with: 745pantethine 300 MG Oral CapsuleSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 746Amyloid PSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 747PulmozymeBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 748AA proteinDesignated preferred name (PT) 
Concepts Starting with: 749NAD^+^ pyrophosphorylaseDesignated preferred name (PT) 
Concepts Starting with: 750nomifensineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 751lamoTRIgine 25 MG Oral Tablet 35 Count PackPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 752AmyloseFull form of descriptor (FN) 
Concepts Starting with: 753PeranexBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 754AnabasineFull form of descriptor (FN) 
Concepts Starting with: 755NubainBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 756AnafranilBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 757Central nervous system stimulantFull form of descriptor (FN) 
Concepts Starting with: 758bismuth subsalicylate 262 MG Chewable Tablet (112) / metroNIDAZOLE 250 MG Oral Tablet (56) / tetracycline HCl 500 MG Oral Capsule (56) PackPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 759prussian blue insoluble 500 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 760AnalgesicDesignated preferred name (PT) 
Concepts Starting with: 761OchratoxinDesignated preferred name (PT) 
Concepts Starting with: 762Kariva 28 Day PackBrand Name Pack (BPCK){# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] 
Concepts Starting with: 763insulin human, rDNA origin Dry Powder InhalerSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 764Arginine carboxypeptidaseDesignated preferred name (PT) 
Concepts Starting with: 765OncoproteinFull form of descriptor (FN) 
Concepts Starting with: 766AnaphylatoxinFull form of descriptor (FN) 
Concepts Starting with: 767Ophthalmic SolutionDose Form (DF) 
Concepts Starting with: 768SynflexBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 769AnaspazBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 770OrnidazoleFull form of descriptor (FN) 
Concepts Starting with: 771AGP - alpha-1 acid glycoproteinSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 772Agkistrodon serine proteinaseDesignated preferred name (PT) 
Concepts Starting with: 773Nonessential amino acidFull form of descriptor (FN) 
Concepts Starting with: 774OsteonectinDesignated preferred name (PT) 
Concepts Starting with: 775Substance with antiandrogen mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 776G-strophanthinSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 777AndrogenSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 778OxazepamDesignated preferred name (PT) 
Concepts Starting with: 779ReductaseDesignated preferred name (PT) 
Concepts Starting with: 780AndrostaneDesignated preferred name (PT) 
Concepts Starting with: 781HbO2 - OxyhemoglobinDesignated preferred name (PT) 
Concepts Starting with: 782OxipurinolDesignated preferred name (PT) 
Concepts Starting with: 783saralasin acetatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. 
Concepts Starting with: 784ADIONE - delta 4-androstenedioneSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 785PAI-1Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 786Water soluble vitaminSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 787tapentadolFull form of descriptor (FN) 
Concepts Starting with: 788PancreatinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 789SulfacitineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 790miconazole Topical Powder [Micatin]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 791ParamethasoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 792ergonovine 0.2 MG [Ergotrate]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 793PargylineDesignated preferred name (PT) 
Concepts Starting with: 794ParvalbuminFull form of descriptor (FN) 
Concepts Starting with: 795CorticoolBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 796PefloxacinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 797thrombin Topical Solution [Thrombogen]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 798Benzylpenicillin-containing productDesignated preferred name (PT) 
Concepts Starting with: 799CotabfluBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 800Dianeal PD-2/4.25Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 801Sodium stibogluconateFull form of descriptor (FN) 
Concepts Starting with: 802Pepsinogen 2Full form of descriptor (FN) 
Concepts Starting with: 803chromic chloride 20.5 MCG (chromium 4 MCG) / copper sulfate 1.57 MG (copper 0.4 MG) / manganese sulfate 0.308 MG (manganese 0.1 MG) / zinc sulfate 4.39 MG (zinc 1 MG) per ML Injectable SolutionSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 804peptonesIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 805PerhexilineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 806Motrin 100 MG Oral TabletPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 807menthol 6.5 MG [Halls]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 808pertussis vaccineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 809carbidopa 10 MG / levodopa 100 MG [Parcopa]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 810lacosamide 50 MG Oral TabletDesignated preferred name (PT) 
Concepts Starting with: 811phenacetinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 812PhenazopyridineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 813PhenindioneDesignated preferred name (PT) 
Concepts Starting with: 814betamethasone / terfenadineMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. 
Concepts Starting with: 815PhenprocoumonIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 816PhenylbutazoneDesignated preferred name (PT) 
Concepts Starting with: 817AnestheticFull form of descriptor (FN) 
Concepts Starting with: 818guaifenesin / pyrilamineTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 819Local anestheticFull form of descriptor (FN) 
Concepts Starting with: 820Anethole trithioneFull form of descriptor (FN) 
Concepts Starting with: 821Phosphatidate phosphataseFull form of descriptor (FN) 
Concepts Starting with: 822carisoprodol / dexamethasone / tenoxicamMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. 
Concepts Starting with: 823Phosphopyruvate carboxylase (GTP)Designated preferred name (PT) 
Concepts Starting with: 824Lecithinase ASynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 825Phosphonacetic acidFull form of descriptor (FN) 
Concepts Starting with: 826Zn(2+) G peptidaseDesignated preferred name (PT) 
Concepts Starting with: 827Phosphorylase phosphataseFull form of descriptor (FN) 
Concepts Starting with: 828Fosphenytoin sodiumDesignated preferred name (PT) 
Concepts Starting with: 829methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG [Utac]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 830bicalutamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 831Angiotensin 1Full form of descriptor (FN) 
Concepts Starting with: 832NexteroneBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 833desmopressin acetate 0.2 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 834Angiotensin 3Full form of descriptor (FN) 
Concepts Starting with: 835PipradrolFull form of descriptor (FN) 
Concepts Starting with: 836Substance with angiotensin-converting enzyme inhibitor mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 837AngiotonaseDesignated preferred name (PT) 
Concepts Starting with: 838AngiotensinogenFull form of descriptor (FN) 
Concepts Starting with: 839AngiotensinFull form of descriptor (FN) 
Concepts Starting with: 840Plasma proteinDesignated preferred name (PT) 
Concepts Starting with: 841T-PAFull form of descriptor (FN) 
Concepts Starting with: 842Platelet activating factorFull form of descriptor (FN) 
Concepts Starting with: 843Platelet factor 4Full form of descriptor (FN) 
Concepts Starting with: 844MinirinBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 845carbamazepine 200 MG Extended Release Oral Capsule [Equetro]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 846benzoyl peroxide 5.25 % Medicated Liquid SoapSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 847vitamin K Oral CapsuleSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 848Humibid L.A. Reformulated Apr 2009Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 849redtop grass pollen extract 100000 UNT/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 850amantadine hydrochloride 100 MG [Mantadine]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 851Anion exchange resinDesignated preferred name (PT) 
Concepts Starting with: 852Pectin depolymeraseDesignated preferred name (PT) 
Concepts Starting with: 853quinidine gluconate 330 MGTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 854Polynucleotide phosphorylaseFull form of descriptor (FN) 
Concepts Starting with: 855benzocaine 15 MG / menthol 4 MG Oral LozengePrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. 
Concepts Starting with: 856Polyoxethylene sorbitan oleateSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 857PVA - Polyvinyl alcoholDesignated preferred name (PT) 
Concepts Starting with: 858PorphyrinDesignated preferred name (PT) 
Concepts Starting with: 859guaiacolsulfonate 60 MG/ML / hydrocodone bitartrate 1 MG/ML [Hydone Formula Liquid]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name 
Concepts Starting with: 860guaifenesin 60 MG/ML / hydrocodone bitartrate 0.7 MG/ML [Codiclear DH]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 861AnserineDesignated preferred name (PT) 
Concepts Starting with: 862Formicidae venomSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 863AntacidDesignated preferred name (PT) 
Concepts Starting with: 864PrednisoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 865AntazolineDesignated preferred name (PT) 
Concepts Starting with: 866antazoline phosphatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. 
Concepts Starting with: 867Acacia pollen extract 1000 UNT/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 868Substance with anthelmintic mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 869AnthocyaninDesignated preferred name (PT) 
Concepts Starting with: 870ProcainamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 871Uridine diphosphate-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 872ProflavineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 873DithranolSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 874ProlixinBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 875Phosphoribosyl-anthranilate pyrophosphorylaseDesignated preferred name (PT) 
Concepts Starting with: 876Anthranilate synthaseFull form of descriptor (FN) 
Concepts Starting with: 877propiomazineFull form of descriptor (FN) 
Concepts Starting with: 878PropofolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 879Product containing propylamine (product)Designated preferred name (PT) 
Concepts Starting with: 880Prostaglandin G/H synthaseSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 881Product containing F series prostaglandin (product)Full form of descriptor (FN) 
Concepts Starting with: 882Antirheumatic agentDesignated preferred name (PT) 
Concepts Starting with: 883Antiarrhythmic agentDesignated preferred name (PT) 
Concepts Starting with: 884Anti-infectivesSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 885Antiseptic agentFull form of descriptor (FN) 
Concepts Starting with: 886ProteoglycanFull form of descriptor (FN) 
Concepts Starting with: 887Antiinflammatory agentFull form of descriptor (FN) 
Concepts Starting with: 888ProtoporphyrinFull form of descriptor (FN) 
Concepts Starting with: 889Nonsteroidal anti-inflammatory agentSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 890aripiprazoleIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 891Calcium Chloride 0.000996 MEQ/ML / Glucose 1.4 MG/ML / Magnesium Chloride 0.0000245 MEQ/ML / NaCl 0.00368 MEQ/ML / Sodium Lactate 0.0016 MEQ/ML Intraperitoneal SolutionSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 892butafosfan 100 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength 
Concepts Starting with: 893Gamma-glu-X carboxypeptidaseDesignated preferred name (PT) 
Concepts Starting with: 894Pulmonary surfactantDesignated preferred name (PT) 
Concepts Starting with: 895Product containing purine nucleoside (product)Designated preferred name (PT) 
Concepts Starting with: 896AntibioticDesignated preferred name (PT) 
Concepts Starting with: 897Substance with aminoglycoside structure and antibacterial mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 898AnthracyclineFull form of descriptor (FN) 
Concepts Starting with: 899sodium bitartrateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 900Antineoplastic antibioticDesignated preferred name (PT) 
Concepts Starting with: 901PyrimethamineDesignated preferred name (PT) 
Concepts Starting with: 902pyritinolDesignated preferred name (PT) 
Concepts Starting with: 903TL-Hist CDBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 904AntibodyFull form of descriptor (FN) 
Concepts Starting with: 905Bifidobacterium infantis 1,000,000,000 UNT per 0.5 GM Oral PowderSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 906ANASynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 907Bacterial antibodyDesignated preferred name (PT) 
Concepts Starting with: 908Antibody to fungusFull form of descriptor (FN) 
Concepts Starting with: 909Helminth antibodyFull form of descriptor (FN) 
Concepts Starting with: 910Heterophile antibodyDesignated preferred name (PT) 
Concepts Starting with: 911Monoclonal immunoglobulinDesignated preferred name (PT) 
Concepts Starting with: 912Replacement preparationFull form of descriptor (FN) 
Concepts Starting with: 913DiflorasoneFull form of descriptor (FN) 
Concepts Starting with: 914Viral antibodyFull form of descriptor (FN) 
Concepts Starting with: 915Rattlesnake venomDesignated preferred name (PT) 
Concepts Starting with: 916Adrenergic receptorFull form of descriptor (FN) 
Concepts Starting with: 917Complement receptorDesignated preferred name (PT) 
Concepts Starting with: 918methyltestosterone 10 MG Oral Tablet [Android-10]Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 919Histamine H1 receptorDesignated preferred name (PT) 
Concepts Starting with: 920Muscarinic receptorFull form of descriptor (FN) 
Concepts Starting with: 921Steroid receptorFull form of descriptor (FN) 
Concepts Starting with: 922Collyrium FreshBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 923AnticoagulantFull form of descriptor (FN) 
Concepts Starting with: 924HYDROmorphone Rectal Suppository [Dilaudid]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 925DrisdolBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 926AnticonvulsantFull form of descriptor (FN) 
Concepts Starting with: 927AntidepressantDesignated preferred name (PT) 
Concepts Starting with: 928Tricyclic antidepressantFull form of descriptor (FN) 
Concepts Starting with: 929Antidiarrheal agentFull form of descriptor (FN) 
Concepts Starting with: 930AntidoteFull form of descriptor (FN) 
Concepts Starting with: 931Antiemetic agentFull form of descriptor (FN) 
Concepts Starting with: 932Mag-Ox 400Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 933glyBURIDE Oral Tablet [Micronase]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 934Naphcon forteBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 935NolahistBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 936OphthocortBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 937Pediaflor DropsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 938citric acid / potassium citrate Oral Solution [Polycitra-K]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 939medroxyPROGESTERone Oral Tablet [Provera]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. 
Concepts Starting with: 940CIC - Circulating immune complexFull form of descriptor (FN) 
Concepts Starting with: 941Slo-bid GyrocapsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 942Sus-Phrine InjectionBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 943Antigenic determinantDesignated preferred name (PT) 
Concepts Starting with: 944perphenazine Injectable Solution [Trilafon]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 945methoxamine Injectable Solution [Vasoxyl]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name 
Concepts Starting with: 946AntigenDesignated preferred name (PT) 
Concepts Starting with: 947Antigen of bacteriaDesignated preferred name (PT) 
Concepts Starting with: 948Cluster of differentiation antigenSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 949Leukocyte 3aSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 950Rutoside-containing productDesignated preferred name (PT) 
Concepts Starting with: 951chloramphenicol Ophthalmic OintmentSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 952SalicylanilideDesignated preferred name (PT) 
Concepts Starting with: 954Antigen of FungusDesignated preferred name (PT) 
Concepts Starting with: 955Helminth antigenDesignated preferred name (PT) 
Concepts Starting with: 956Heterophil antigenFull form of descriptor (FN) 
Concepts Starting with: 957ichthammol 20 % Topical OintmentSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form 
Concepts Starting with: 959Fibrous proteinDesignated preferred name (PT) 
Concepts Starting with: 960Hyoscine-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 961Antigen of ProtozoaFull form of descriptor (FN) 
Concepts Starting with: 962QuinalbarbitoneFull form of descriptor (FN) 
Concepts Starting with: 963Thymus-independent antigenDesignated preferred name (PT) 
Concepts Starting with: 964seleniteIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 965Antigen of virusFull form of descriptor (FN) 
Concepts Starting with: 966levothyroxine sodium 0.025 MG Oral Tablet [Eltroxin]Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 967SerentilBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient. 
Concepts Starting with: 968Antihypertensive agentFull form of descriptor (FN) 
Concepts Starting with: 969miconazole Buccal TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form 
Concepts Starting with: 970Buccal TabletDose Form (DF) 
Concepts Starting with: 971Anti lymphocyte antibodyDesignated preferred name (PT) 
Concepts Starting with: 972Anas platyrhynchos allergenic extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). 
Concepts Starting with: 973Antilymphocyte immunoglobulinFull form of descriptor (FN) 
Concepts Starting with: 974Product containing Salmonella typhimurium antiserum (medicinal product)Full form of descriptor (FN) 
Concepts Starting with: 975Substance with antimalarial mechanism of actionFull form of descriptor (FN) 
Concepts Starting with: 976AntimetaboliteFull form of descriptor (FN) 
Concepts Starting with: 977N-methyl-L-amino-acid oxidaseFull form of descriptor (FN) 
Concepts Starting with: 978Substance with mitotic inhibitor mechanism of actionFull form of descriptor (FN) 
Concepts Starting with: 979Prephytoene-diphosphate synthaseDesignated preferred name (PT) 
Concepts Starting with: 980SincalideDesignated preferred name (PT) 
Concepts Starting with: 981Antimony potassium tartrateFull form of descriptor (FN) 
Concepts Starting with: 982Nucleoside phosphoacylhydrolaseFull form of descriptor (FN) 
Concepts Starting with: 983Antimony sodium tartrateFull form of descriptor (FN) 
Concepts Starting with: 984Substance with muscarinic receptor antagonist mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 985Complement component, precursorDesignated preferred name (PT) 
Concepts Starting with: 986Cephalothin sodiumBritish preferred term (PTGB) 
Concepts Starting with: 987Blood group antigen HofDesignated preferred name (PT) 
Concepts Starting with: 988Antineoplastic agentDesignated preferred name (PT) 
Concepts Starting with: 989Blood group antibody BocDesignated preferred name (PT) 
Concepts Starting with: 990Benzylpenicillin sodiumFull form of descriptor (FN) 
Concepts Starting with: 991Sodium taurocholateDesignated preferred name (PT) 
Concepts Starting with: 992Blood group antigen Sp>1<Synonym (SY)Synonym of another TTY, given for clarity. 
Concepts Starting with: 993Blood group antibody Pr>a<Designated preferred name (PT) 
Concepts Starting with: 994Blood group antigen HaaseFull form of descriptor (FN) 
Concepts Starting with: 995Antiparkinsonian agentFull form of descriptor (FN) 
Concepts Starting with: 996Alpha-2-antiplasminFull form of descriptor (FN) 
Concepts Starting with: 997Blood group antibody CrossDesignated preferred name (PT) 
Concepts Starting with: 998Substance with antiprotozoal mechanism of actionDesignated preferred name (PT) 
Concepts Starting with: 999SpiperoneFull form of descriptor (FN)